Logo
Secure Registration

International Conference on HIV Research and Clinical Trials

ICHRCT

17th Mar – 18th Mar 2027 Puno, Peru

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

1

Select Registration Mode

2

Participant Details

3

Coupon Code

4

Terms & Condition

Read the full Terms & Conditions

Conference Session Tracks

UN SDG Wheel

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

SDG 3 SDG 4 SDG 9
01 Advancements in HIV Molecular Diagnostics +
This track will explore the latest innovations in molecular diagnostic techniques for HIV detection and monitoring. Emphasis will be placed on the integration of novel biomarkers and technologies in clinical practice.
SDG 3 SDG 4
02 Innovative Therapeutic Approaches in HIV Treatment +
This session will focus on cutting-edge therapeutic innovations aimed at improving patient outcomes in HIV management. Discussions will include novel antiretroviral therapies and combination strategies.
SDG 3 SDG 4
03 Translational Research in HIV: Bridging Bench to Bedside +
This track will highlight translational research efforts that aim to convert laboratory findings into clinical applications for HIV treatment and prevention. Participants will discuss the challenges and successes in this critical area.
SDG 3 SDG 9
04 Patient-Centered Care in HIV Management +
This session will address the importance of patient-centered approaches in HIV care, including adherence strategies and psychosocial support. The role of healthcare providers in fostering patient engagement will also be examined.
SDG 3 SDG 4
05 Biomarker Discovery for HIV Disease Progression +
This track will focus on the identification and validation of biomarkers that can predict disease progression in HIV-infected individuals. Researchers will present their findings on potential clinical applications of these biomarkers.
SDG 3 SDG 9
06 Public Health Strategies for HIV Prevention +
This session will discuss effective public health strategies aimed at reducing HIV transmission rates globally. Topics will include community-based interventions, education, and policy initiatives.
SDG 3 SDG 4
07 Laboratory Techniques in HIV Research +
This track will cover advanced laboratory techniques utilized in HIV research, including cell culture, viral load testing, and genetic sequencing. Participants will share insights on optimizing these methodologies for enhanced research outcomes.
SDG 3 SDG 9
08 Understanding HIV Disease Mechanisms +
This session will delve into the underlying mechanisms of HIV pathogenesis and immune response. Researchers will present their latest findings on viral replication, host interactions, and immune evasion strategies.
SDG 3 SDG 4
09 Clinical Trials: Design and Implementation in HIV Research +
This track will focus on the design and implementation of clinical trials in HIV research, including challenges in recruitment and retention. Best practices for ensuring trial integrity and participant safety will be discussed.
SDG 3 SDG 4
10 Global Perspectives on HIV Research +
This session will provide a platform for discussing global perspectives on HIV research and clinical trials. Participants will share insights on regional challenges, successes, and collaborative efforts in combating HIV.
SDG 3 SDG 4
11 Emerging Trends in HIV Vaccine Development +
This track will explore the latest developments in HIV vaccine research, including novel approaches and clinical trial outcomes. The session will address the scientific and ethical considerations surrounding vaccine development.
SDG 3 SDG 4